Search results
Results from the WOW.Com Content Network
Estrogen also rises during pregnancy, and that, combined with progesterone, can contribute to the formation of melasma, which appears as dark brown spots or patches. ... can contribute to the ...
Melasma is a skin condition characterized by a darkening of the skin. ... Pregnancy can cause estrogen and progesterone levels to increase, which can also lead to the occurrence of melasma in some ...
The exact cause of melasma is unknown, says Dr. Robert Finney, MD, a board-certified dermatologist in New York City. But it’s believed to result from the skin’s pigment-producing cells being ...
Melasma (also known as chloasma faciei, [1]: 854 or the mask of pregnancy [2] when present in pregnant women) is a tan or dark skin discoloration. Melasma is thought to be caused by sun exposure, genetic predisposition, hormone changes, and skin irritation. [ 3 ]
Liver cirrhosis is another cause, though through lowered metabolism of estrogen, not oversecretion or overconsumption like the aforementioned. It's necessary to know there exist two kinds of hyperestrogenism: Absolute (more concentration than usual of estrogen) and relative (a normal concentration of estrogen, higher with respect to progesterone).
High-dose estrogen therapy (HDE) is a type of hormone therapy in which high doses of estrogens are given. [1] When given in combination with a high dose of progestogen , it has been referred to as pseudopregnancy .
Antioxidants: Free radical damage (which you can get from sun exposure) is a known cause of skin pigmentation disorders, including melasma. Antioxidants, like niacinamide and retinol (vitamin A ...
List of side effects of estradiol which may occur as a result of its use or have been associated with estrogen and/or progestogen therapy includes: [1] [2]. Gynecological: changes in vaginal bleeding, dysmenorrhea, increase in size of uterine leiomyomata, vaginitis including vaginal candidiasis, changes in cervical secretion and cervical ectropion, ovarian cancer, endometrial hyperplasia ...